Skip to content

GENTEX CORPORATION: 10-Q filed 2024-11-01

What GENTEX CORPORATION reported in its quarterly report filed 2024-11-01 (fiscal Q3 2024): 48 published measures, 135 facts as tagged in accession 0000355811-24-000048.

This filing

Form
10-Q (quarterly report)
Filed
2024-11-01
Fiscal period
fiscal Q3 2024
Accession
0000355811-24-000048 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENTEX CORPORATION filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-302,735,296,843USD
At 2023-12-312,611,437,552USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-30317,669,501USD
At 2023-12-31298,920,483USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-302,417,627,342USD
At 2024-06-302,400,299,527USD
At 2023-12-312,312,517,069USD
At 2023-09-302,268,453,807USD
At 2023-06-302,195,949,326USD
At 2022-12-312,065,792,821USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-09-30179,639,743USD
At 2023-12-31226,435,019USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30122,549,041USD92
2024-01-01 to 2024-09-30316,820,194USD274
2023-07-01 to 2023-09-30104,725,412USD92
2023-01-01 to 2023-09-30311,459,076USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-30343,817,752USD274
2023-01-01 to 2023-09-30367,668,306USD273

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2024-07-01 to 2024-09-30608,525,777USD92
2024-01-01 to 2024-09-301,771,676,766USD274
2023-07-01 to 2023-09-30575,848,490USD92
2023-01-01 to 2023-09-301,710,082,647USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-243,730,011USD274
2023-01-01 to 2023-09-30-136,713,585USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-146,883,017USD274
2023-01-01 to 2023-09-30-189,075,734USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-301,405,918,157USD
At 2023-12-311,336,940,990USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-07-01 to 2024-09-30226,002,347shares92
2024-01-01 to 2024-09-30226,646,541shares274
2023-07-01 to 2023-09-30230,047,014shares92
2023-01-01 to 2023-09-30229,866,008shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-07-01 to 2024-09-30226,241,684shares92
2024-01-01 to 2024-09-30227,009,932shares274
2023-07-01 to 2023-09-30230,457,411shares92
2023-01-01 to 2023-09-30230,181,674shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-07-01 to 2024-09-300.54USD/shares92
2024-01-01 to 2024-09-301.38USD/shares274
2023-07-01 to 2023-09-300.45USD/shares92
2023-01-01 to 2023-09-301.33USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-07-01 to 2024-09-300.53USD/shares92
2024-01-01 to 2024-09-301.38USD/shares274
2023-07-01 to 2023-09-300.45USD/shares92
2023-01-01 to 2023-09-301.33USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-07-01 to 2024-09-3022,906,309USD92
2024-01-01 to 2024-09-3057,614,063USD274
2023-07-01 to 2023-09-3019,754,749USD92
2023-01-01 to 2023-09-3057,619,971USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2024-09-30703,583,489USD
At 2023-12-31652,877,672USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2024-01-01 to 2024-09-3030,936,895USD274
2023-01-01 to 2023-09-3029,212,236USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-30125,728,152USD92
2024-01-01 to 2024-09-30369,958,486USD274
2023-07-01 to 2023-09-30122,416,529USD92
2023-01-01 to 2023-09-30362,956,564USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-301,045,684,218USD
At 2023-12-31997,738,153USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-30283,164,653USD
At 2023-12-31271,608,976USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-09-30182,606,296USD
At 2023-12-31184,398,820USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2024-09-30340,105,631USD
At 2023-12-31340,105,631USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2024-09-30356,338,008USD
At 2023-12-31321,809,868USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2024-01-01 to 2024-09-30184,609,148USD274
2023-01-01 to 2023-09-3076,859,341USD273

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-07-01 to 2024-09-3078,335,483USD92
2024-01-01 to 2024-09-30224,906,065USD274
2023-07-01 to 2023-09-3069,024,104USD92
2023-01-01 to 2023-09-30196,304,339USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2024-09-30449,311,020USD
At 2023-12-31402,473,028USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30204,063,635USD92
2024-01-01 to 2024-09-30594,864,551USD274
2023-07-01 to 2023-09-30191,440,633USD92
2023-01-01 to 2023-09-30559,260,903USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2024-07-01 to 2024-09-3030,109,515USD92
2024-01-01 to 2024-09-3090,494,117USD274
2023-07-01 to 2023-09-3028,826,587USD92
2023-01-01 to 2023-09-3083,479,285USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-07-01 to 2024-09-3048,225,968USD92
2024-01-01 to 2024-09-30134,411,948USD274
2023-07-01 to 2023-09-3040,197,517USD92
2023-01-01 to 2023-09-30112,825,054USD273

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-09-30179,639,743USD
At 2023-12-31226,435,019USD
At 2023-09-30260,633,625USD
At 2022-12-31218,754,638USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2024-09-30-2,885,924USD
At 2023-12-31-6,557,122USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2024-09-305,363,370USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2024-09-30201,604,035USD
At 2023-12-31214,005,910USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-09-30986,029,136USD
At 2023-12-31960,821,727USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2024-09-3034,504,848USD
At 2023-12-3127,311,507USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-09-30100,558,357USD
At 2023-12-3187,210,156USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2024-09-3039,932,866USD
At 2023-12-3132,663,762USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30145,455,350USD92
2024-01-01 to 2024-09-30374,434,257USD274
2023-07-01 to 2023-09-30124,480,161USD92
2023-01-01 to 2023-09-30369,079,047USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2024-07-01 to 2024-09-30127,638,770USD92
2024-01-01 to 2024-09-30320,491,392USD274
2023-07-01 to 2023-09-30104,295,440USD92
2023-01-01 to 2023-09-30311,929,270USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2024-01-01 to 2024-09-3070,887,294USD274
2023-01-01 to 2023-09-3071,001,177USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2024-07-01 to 2024-09-304,500,000USD92
2024-01-01 to 2024-09-3013,400,000USD274
2023-07-01 to 2023-09-305,200,000USD92
2023-01-01 to 2023-09-3015,600,000USD273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2024-07-01 to 2024-09-30744,569USD92
2024-01-01 to 2024-09-301,255,438USD274
2023-07-01 to 2023-09-30-1,788,335USD92
2023-01-01 to 2023-09-30-3,559,613USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2024-09-3019,727,198USD92
2024-01-01 to 2024-09-304,475,771USD274
2023-07-01 to 2023-09-302,063,632USD92
2023-01-01 to 2023-09-306,122,483USD273

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-9,970,207USD274
2023-01-01 to 2023-09-30-11,870,944USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-01-01 to 2024-09-3024,024,353USD274
2023-01-01 to 2023-09-3024,304,861USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-3034,528,140USD274
2023-01-01 to 2023-09-3074,648,395USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-3046,837,992USD274
2023-01-01 to 2023-09-30-8,907,490USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-8,976,998USD274
2023-01-01 to 2023-09-3027,451,773USD273

Inspect the source

Entity
GENTEX CORPORATION / CIK 0000355811
Captured
2026-09-19T14:57:30.647Z
SEC response SHA-256
eb99451c516d46096834feea4e32d587225b1e40e8c07b7e0c0a0961878fc624

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000355811.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))